Arginine/Ibuprofen/Codeine Phosphate

精氨酸/布洛芬/磷酸可待因

Report date: 2025/07/30 14:53:59

Base Information

Drug NameArginine/Ibuprofen/Codeine Phosphate
Drug Alias Name精氨洛芬待因片精布待因片
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsOpioid receptors agonists
TargetsCyclooxygenasesOpioid receptors
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes ArginineIbuprofenCodeine Phosphate
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChina Resources Sanjiu Medical & Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu High-Tech Entrepreneurship Service CenterChina Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A